China Pharma Holdings, Inc. (CPHI)
0.612
-0.02
(-3.04%)
USD |
NYAM |
Feb 20, 16:00
0.618
+0.01
(+0.98%)
After-Hours: 20:00
China Pharma Holdings Enterprise Value : 6.347M for Feb. 20, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Linike Medical Group Ltd. | -- |
| Yubo International Biotech Ltd. | 1.961M |
| Ernexa Therapeutics, Inc. | -0.0979M |
| Recursion Pharmaceuticals, Inc. | 1.199B |
| Tango Therapeutics, Inc. | 1.524B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.6515M |
| Revenue (Quarterly) | 0.7562M |
| Total Expenses (Quarterly) | 1.408M |
| EPS Diluted (Quarterly) | -0.1682 |
| Gross Profit Margin (Quarterly) | -34.07% |
| Profit Margin (Quarterly) | -86.15% |
| Earnings Yield | -168.4% |
| Normalized Earnings Yield | -168.45 |